Brief: Myriad Genetics Q1 Operating Income USD -29 Million
06/05/2025 21:05
May 06 (Reuters) - Myriad Genetics Q1 gross margin 69%. Q1 adjusted operating expenses USD 140.6 million Q1 operating expenses USD 163.2 million Q1 adjusted operating income USD -5.5 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple